Product Information
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $1.1738 per EA under NDC 65862049730. Its NADAC has been published 253 times since Aug 25, 2021.
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB
Efavirenz, Emtricitabine and Tenofovir Disoproxil FumarateStrength
600; 200; 300 mg/1; mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862049730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA203041On Market Since
3/30/2021
Pharmacological Classes
Price Statistics
The NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has been published 253 times since Aug 25, 2021, and over the history we have for it it has declined 77.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1738 per EA |
|---|---|
| All-time high | $7.0703 (Dec 15, 2021) |
| All-time low | $1.1460 (Jul 17, 2024) |
| 52-week high | $1.6592 |
| 52-week low | $1.1738 |
| Median price | $1.6923 |
| Average price | $3.0109 |
| Largest weekly change | -74.7% (Aug 23, 2023) |
| Weeks tracked | 253 |
| Tracking since | Aug 25, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB, manufactured by Aurobindo Pharma Limited, is $1.1738 per EA (NDC 65862049730), effective Jun 24, 2026.
How has the price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB changed over time?
Over the history we have for it, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has declined 77.0%. It has been tracked across 253 weekly CMS publications since Aug 25, 2021.
What are the highest and lowest recorded NADAC prices for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
Since Aug 25, 2021, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has ranged from a low of $1.1460 (Jul 17, 2024) to a high of $7.0703 (Dec 15, 2021), with a median of $1.6923 per EA.
Are there cheaper alternatives to EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
3 NADAC-published products share the same active ingredient, strength, and dosage form as EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB, but none are currently priced below it.
Who manufactures EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB (NDC 65862049730) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification